ANDREA B BOONE

Allopathic & Osteopathic Physicians|Obstetrics & Gynecology VISALIA, CA NPI 1528016235

General Payments — all program years on this page

$3,500.70

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 208
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $356.71 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $356.7119

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $354.2925
2019 $213.0914
2020 $209.5014
2021 $705.5547
2022 $909.0053
2023 $752.5636
2024 $356.7119

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1084875140 Hologic Sales and Service, LLC $26.64 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131496426 PFIZER INC. $22.77 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136210599 Organon Llc $13.25 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139370381 Astellas Pharma US Inc $22.42 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139380944 Astellas Pharma US Inc $18.82 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141835758 Merck Sharp & Dohme LLC $21.95 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148829909 Sumitomo Pharma America, Inc. $11.14 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148829911 Sumitomo Pharma America, Inc. $17.16 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148829913 Sumitomo Pharma America, Inc. $24.58 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148829915 Sumitomo Pharma America, Inc. $15.34 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148829917 Sumitomo Pharma America, Inc. $7.45 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148829919 Sumitomo Pharma America, Inc. $16.43 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148829921 Sumitomo Pharma America, Inc. $7.79 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148829923 Sumitomo Pharma America, Inc. $21.53 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148829925 Sumitomo Pharma America, Inc. $18.20 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149987755 Exeltis, USA Inc. $24.48 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149987760 Exeltis, USA Inc. $23.52 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150796791 CooperSurgical, Inc. $20.49 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154841064 Agile Therapeutics, Inc. $22.75 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.